Human cell

Single-Cell Advances in Functional Immune Monitoring for Developing Immune Therapies and Uncovering Disease Pathogenesis

GEN spoke to three thought leaders working on immune therapies to hear their views and strategies on using single-cell functional proteomics in their quest to treat some of the world’s most devastating diseases. Read this IsoPlexis sponsored Roundtable now!
From Capture to Discovery: Using Data to Drive Research & Generate Outcomes cover image

From Capture to Discovery: Using Data to Drive Research & Generate Outcomes

This eBook's collection of articles highlight the role of data in life sciences, some of the workloads that are creating this influx of data, and the importance of data management. Read this Dell Technologies and Nvidia sponsored eBook now.
Ribosome, illustration

Making the Promise of mRNA a Reality: Overcoming Scale-Up Challenges

This eBook shows how to approach the daunting landscape of scaling up in vitro transcription. It also emphasizes that the mRNA journey is actually an expedition—an undertaking that demands teamwork. The scale-up of mRNA production occurs more reliably and efficiently if developers have good relationships with suppliers and technical specialists.
Single Use Support's DSC8833

Single-Use Technologies

Fueled by the improved performance of SUTs, Single Use Support is committed to preventing future bottlenecks for single-use systems. Our slogan, “Pioneering Biopharma,” is manifested in our corporate DNA, and that sentiment will drive us to help advance the pharmaceutical industry. Read our eBook now!

Sequencing Assays for Biomarker Discovery and Pharmacodynamics in Oncology Studies

In this eBook, sponsored by Frontage, we navigate the landscape of biomarker discovery through genomic profiling, exploring technologies, methods, and applications. We hope this collection of articles creates an appreciation for the wide scope of using sequencing assays for biomarker discovery, drug development, and beyond.
Perspectives Toward a Treatment for Early Onset Alzheimer’s Disease eBook cover image

Perspectives Toward a Treatment for Early Onset Alzheimer’s Disease

In this Roundtable we have the CSO and director of research of a startup biotech company, Paros Bio, and experts from their partnering contract research organization (CRO), Charles River, discussing the specifics of their work and productive partnership. This discussion focuses on the emergence of Paros Bio, the science behind their PSEN1 program for Autosomal Dominant Alzheimer’s Disease (ADAD), and the perspectives from experts at both companies on the nature of their work and alliance.

Cryo-EM Trends for Drug Discovery

This eBook, sponsored by Thermo Fisher Scientific, shows just some of the things that can be done with cryo-EM. We hope you will see how much the technique has matured, and how the microscopes themselves have become more intelligent, enabling users to focus on the science, instead of on the machine.
Cytiva lab, Via Freeze Vials

Optimal Cryogenic Cooling

It’s essential to let science dispel such uncertainties. That’s why Cytiva presents evidence in this eBook that reveals an optimal cooling profile—avoiding too fast, and too slow.
Delivering the Goods, Bringing the Heat eBook image

Delivering the Goods, Bringing the Heat

When we battle disease, we need options other than brute force. We need precision weapons. And for many therapeutic applications, the precision weapons of choice are functionalized nanoparticles. This eBook, sponsored by Fortis Life Sciences, locates nanoparticles in the current order of battle. The battle in question is, of course, the battle between medical science and disease.
Ampules on the table close-up.

Overcoming the Challenges of Infectious Diseases with Label-Free Approaches

In response to the global COVID-19 pandemic, vaccine research and manufacturing processes have seen unprecedented advancements over a short timeframe. This eBook, sponsored by Sartorius, explores the latest methodologies and suggests alternative strategies in the development of future vaccines to fight the huge variety of infectious diseases.